Umar Medicare Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.00 M
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 5.00 M
- Revenue Growth 268.74%
- Profit Growth 87.92%
- Ebitda -98.58%
- Net Worth 102.56%
- Total Assets 441.19%
About Umar Medicare
Umar Medicare Private Limited (UMPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 January 2020 (Five years and one month 15 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹5.00 M.
Ankur Tyagi and Gitanjali Tyagi serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909DL2020PTC359915
- Company No.
359915
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jan 2020
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Umar Medicare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ankur Tyagi  | Director | 07-Jan-2020 | Current |
| Gitanjali Tyagi | Director | 01-Oct-2020 | Current |
Financial Performance of Umar Medicare.
Umar Medicare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 268.74% increase. The company also saw a substantial improvement in profitability, with a 87.92% increase in profit. The company's net worth Soared by an impressive increase of 102.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Umar Medicare?
In 2020, Umar Medicare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eshar Healthcare Private LimitedAnkur Tyagi is a mutual person
- Ukar Remedy Private Limited
Ankur Tyagi is a mutual person
Charges (Loans)
₹5.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Mar 2022 | Others | ₹5.00 M | Open |
How Many Employees Work at Umar Medicare?
Unlock and access historical data on people associated with Umar Medicare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Umar Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Umar Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
